The effects of IL-6 on CD4 T cell responses

Clinical Immunology

Volumn 130, Issue 1, 2009, Pages 27-33

  Dienz, Oliver ^a   Rincon, Mercedes ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Allergic airway inflammation; Autoimmune disease; CD4 T cell differentiation; IL 21; IL 6; IL 6R; T helper response; Th1 Th2 Th17

Indexed keywords

INTERLEUKIN 21; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; EFFECTOR CELL; GERMINAL CENTER; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL SURVIVAL; HUMANS; INTERLEUKIN-6; RECEPTORS, INTERLEUKIN-6; SIGNAL TRANSDUCTION;

EID: 57149107119     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.08.018     Document Type: Review

References (61)

1. Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A., et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324 (1986) 73-76
2. Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis. Res. Ther. 8 Suppl. 2 (2006) S2
3. Kamimura D., Ishihara K., and Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev. Physiol. Biochem. Pharmacol. 149 (2003) 1-38
4. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., and Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374 (2003) 1-20
5. Boulanger M.J., Chow D.C., Brevnova E.E., and Garcia K.C. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex. Science 300 (2003) 2101-2104
6. Zhong Z., Wen Z., and Darnell Jr. J.E. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264 (1994) 95-98
7. Gerhartz C., Heesel B., Sasse J., Hemmann U., Landgraf C., Schneider-Mergener J., Horn F., Heinrich P.C., and Graeve L. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation. J. Biol. Chem. 271 (1996) 12991-12998
8. Ramji D.P., Vitelli A., Tronche F., Cortese R., and Ciliberto G. The two C/EBP isoforms, IL-6DBP/NF-IL6 and C/EBP delta/NF-IL6 beta, are induced by IL-6 to promote acute phase gene transcription via different mechanisms. Nucleic Acids Res. 21 (1993) 289-294
9. Chen R.H., Chang M.C., Su Y.H., Tsai Y.T., and Kuo M.L. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J. Biol. Chem. 274 (1999) 23013-23019
10. Saito M., Yoshida K., Hibi M., Taga T., and Kishimoto T. Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. J. Immunol. 148 (1992) 4066-4071
11. Scheller J., and Rose-John S. Interleukin-6 and its receptor: from bench to bedside. Med. Microbiol. Immunol. 195 (2006) 173-183
12. Mullberg J., Schooltink H., Stoyan T., Gunther M., Graeve L., Buse G., Mackiewicz A., Heinrich P.C., and Rose-John S. The soluble interleukin-6 receptor is generated by shedding. Eur. J. Immunol. 23 (1993) 473-480
13. Horiuchi S., Koyanagi Y., Zhou Y., Miyamoto H., Tanaka Y., Waki M., Matsumoto A., Yamamoto M., and Yamamoto N. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur. J. Immunol. 24 (1994) 1945-1948
14. Atreya R., Mudter J., Finotto S., Mullberg J., Jostock T., Wirtz S., Schutz M., Bartsch B., Holtmann M., Becker C., Strand D., Czaja J., Schlaak J.F., Lehr H.A., Autschbach F., Schurmann G., Nishimoto N., Yoshizaki K., Ito H., Kishimoto T., Galle P.R., Rose-John S., and Neurath M.F. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat. Med. 6 (2000) 583-588
15. Jostock T., Mullberg J., Ozbek S., Atreya R., Blinn G., Voltz N., Fischer M., Neurath M.F., and Rose-John S. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur. J. Biochem. 268 (2001) 160-167
16. Briso E.M., Dienz O., and Rincon M. Cutting edge: soluble IL-6R is produced by IL-6R ectodomain shedding in activated CD4 T cells. J. Immunol. 180 (2008) 7102-7106
17. Teague T.K., Marrack P., Kappler J.W., and Vella A.T. IL-6 rescues resting mouse T cells from apoptosis. J. Immunol. 158 (1997) 5791-5796
18. Lotz M., Jirik F., Kabouridis P., Tsoukas C., Hirano T., Kishimoto T., and Carson D.A. B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J. Exp. Med. 167 (1988) 1253-1258
19. Kishimoto H., and Sprent J. Strong TCR ligation without costimulation causes rapid onset of Fas-dependent apoptosis of naive murine CD4+ T cells. J. Immunol. 163 (1999) 1817-1826
20. Ayroldi E., Zollo O., Cannarile L., Grohmann D.A.F.U., Delfino D.V., and Riccardi C. Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/fasL expression and cell death. Blood 92 (1998) 4212-4219
21. Rochman I., Paul W.E., and Ben-Sasson S.Z. IL-6 increases primed cell expansion and survival. J. Immunol. 174 (2005) 4761-4767
22. Longhi M.P., Wright K., Lauder S.N., Nowell M.A., Jones G.W., Godkin A.J., Jones S.A., and Gallimore A.M. Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells. PLoS Pathog. 4 (2008) e1000006
23. Weissenbach M., Clahsen T., Weber C., Spitzer D., Wirth D., Vestweber D., Heinrich P.C., and Schaper F. Interleukin-6 is a direct mediator of T cell migration. Eur. J. Immunol. 34 (2004) 2895-2906
24. Rincon M., Anguita J., Nakamura T., Fikrig E., and Flavell R.A. Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J. Exp. Med. 185 (1997) 461-469
25. Diehl S., Chow C.W., Weiss L., Palmetshofer A., Twardzik T., Rounds L., Serfling E., Davis R.J., Anguita J., and Rincon M. Induction of NFATc2 expression by interleukin 6 promotes T helper type 2 differentiation. J. Exp. Med. 196 (2002) 39-49
26. Dienz O., Eaton S.M., Krahl T.J., Diehl S., Charland C., Dodge J., Swain S.L., Budd R.C., Haynes L., and Rincon M. Accumulation of NFAT mediates IL-2 expression in memory, but not naive, CD4+ T cells. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 7175-7180
27. Yang T.T., Ung P.M., Rincon M., and Chow C.W. Role of the CCAAT/enhancer-binding protein NFATc2 transcription factor cascade in the induction of secretory phospholipase A2. J. Biol. Chem. 281 (2006) 11541-11552
28. Yang Y., Ochando J., Yopp A., Bromberg J.S., and Ding Y. IL-6 plays a unique role in initiating c-Maf expression during early stage of CD4 T cell activation. J. Immunol. 174 (2005) 2720-2729
29. Kim J.I., Ho I.C., Grusby M.J., and Glimcher L.H. The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity 10 (1999) 745-751
30. Walker C., Bauer W., Braun R.K., Menz G., Braun P., Schwarz F., Hansel T.T., and Villiger B. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am. J. Respir. Crit. Care Med. 150 (1994) 1038-1048
31. Wang J., Homer R.J., Chen Q., and Elias J.A. Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation. J. Immunol. 165 (2000) 4051-4061
32. Finotto S., Eigenbrod T., Karwot R., Boross I., Doganci A., Ito H., Nishimoto N., Yoshizaki K., Kishimoto T., Rose-John S., Galle P.R., and Neurath M.F. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells. Int. Immunol. 19 (2007) 685-693
33. Diehl S., Anguita J., Hoffmeyer A., Zapton T., Ihle J.N., Fikrig E., and Rincon M. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 13 (2000) 805-815
34. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., and Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6 (2005) 1123-1132
35. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., and Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 (2006) 235-238
36. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., and Weaver C.T. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006) 231-234
37. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., and Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
38. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., Basham B., Smith K., Chen T., Morel F., Lecron J.C., Kastelein R.A., Cua D.J., McClanahan T.K., Bowman E.P., and de Waal Malefyt R. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8 (2007) 950-957
39. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., and Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8 (2007) 942-949
40. Yang L., Anderson D.E., Baecher-Allan C., Hastings W.D., Bettelli E., Oukka M., Kuchroo V.K., and Hafler D.A. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454 (2008) 350-352
41. Volpe E., Servant N., Zollinger R., Bogiatzi S.I., Hupe P., Barillot E., and Soumelis V. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat. Immunol. 9 (2008) 650-657
42. Manel N., Unutmaz D., and Littman D.R. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9 (2008) 641-649
43. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., and Wahl S.M. Conversion of peripheral CD4+ CD25- naive T cells to CD4+ CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003) 1875-1886
44. Pasare C., and Medzhitov R. Toll pathway-dependent blockade of CD4+ CD25+ T cell-mediated suppression by dendritic cells. Science 299 (2003) 1033-1036
45. Dominitzki S., Fantini M.C., Neufert C., Nikolaev A., Galle P.R., Scheller J., Monteleone G., Rose-John S., Neurath M.F., and Becker C. Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+ CD25 T cells. J. Immunol. 179 (2007) 2041-2045
46. Ivanov, McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., and Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 (2006) 1121-1133
47. Yang X.O., Pappu B.P., Nurieva R., Akimzhanov A., Kang H.S., Chung Y., Ma L., Shah B., Panopoulos A.D., Schluns K.S., Watowich S.S., Tian Q., Jetten A.M., and Dong C. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28 (2008) 29-39
48. Ichiyama K., Yoshida H., Wakabayashi Y., Chinen T., Saeki K., Nakaya M., Takaesu G., Hori S., Yoshimura A., and Kobayashi T. Foxp3 inhibits ROR{gamma}t-mediated IL-17A mRNA transcription through direct interaction with ROR{gamma}t. J. Biol. Chem. 283 (2008) 17003-17008
49. Ozaki K., Spolski R., Feng C.G., Qi C.F., Cheng J., Sher A., Morse III H.C., Liu C., Schwartzberg P.L., and Leonard W.J. A critical role for IL-21 in regulating immunoglobulin production. Science 298 (2002) 1630-1634
50. Coquet J.M., Kyparissoudis K., Pellicci D.G., Besra G., Berzins S.P., Smyth M.J., and Godfrey D.I. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J. Immunol. 178 (2007) 2827-2834
51. Wurster A.L., Rodgers V.L., Satoskar A.R., Whitters M.J., Young D.A., Collins M., and Grusby M.J. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J. Exp. Med. 196 (2002) 969-977
52. Zhou L., Ivanov II, Spolski R., Min R., Shenderov K., Egawa T., Levy D.E., Leonard W.J., and Littman D.R. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8 (2007) 967-974
53. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., Schluns K., Tian Q., Watowich S.S., Jetten A.M., and Dong C. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448 (2007) 480-483
54. Korn T., Bettelli E., Gao W., Awasthi A., Jager A., Strom T.B., Oukka M., and Kuchroo V.K. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448 (2007) 484-487
55. Suto A., Kashiwakuma D., Kagami S., Hirose K., Watanabe N., Yokote K., Saito Y., Nakayama T., Grusby M.J., Iwamoto I., and Nakajima H. Development and characterization of IL-21-producing CD4+ T cells. J. Exp. Med. 205 (2008) 1369-1379
56. Yadav M., Rosenbaum J., and Goetzl E.J. Cutting edge: vasoactive intestinal peptide (VIP) induces differentiation of Th17 cells with a distinctive cytokine profile. J. Immunol. 180 (2008) 2772-2776
57. Wei L., Laurence A., Elias K.M., and O'Shea J.J. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J. Biol. Chem. 282 (2007) 34605-34610
58. Sonderegger I., Kisielow J., Meier R., King C., and Kopf M. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur. J. Immunol. 38 (2008) 1833-1838
59. Coquet J.M., Chakravarti S., Smyth M.J., and Godfrey D.I. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J. Immunol. 180 (2008) 7097-7101
60. King C., Tangye S.G., and Mackay C.R. T follicular helper (T(FH)) cells in normal and dysregulated immune responses. Annu. Rev. Immunol. 26 (2008) 741-766
61. Chtanova T., Tangye S.G., Newton R., Frank N., Hodge M.R., Rolph M.S., and Mackay C.R. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 173 (2004) 68-78